Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
- Refer to NICE TA607.
- Low dose rivaroxaban 2.5mg twice daily (i.e. a quarter of the usual daily anticoagulant dose) plus aspirin 75mg daily is recommended as an option (under specialist guidance) for preventing atherothrombotic events in adults with coronary artery disease or symptomatic peripheral artery disease who are at high risk of ischaemic events.
- Clinicians should carefully assess if bleeding risk outweighs potential benefit in individual patients.